When Oswald Bilotta landed his dream job as a sales representative for Novartis Pharmaceuticals in 1999, he had no idea that just over a decade later he'd be part of a vast federal investigation into company kickbacks and paying cash bribes to doctors while wearing a wire for prosecutors. On July 1, his yearslong effort to blow the whistle at Novartis paid off. The Justice Department announced a $678 million settlement with the company over improper inducements it made to doctors to prescribe 10 of the company's drugs, including the anti-hypertension drug Lotrel. "The whole system needed to be blown up and pieced together in a fair way — fair for taxpayers and good for patients," he said. | 
No comments:
Post a Comment